Dr. Sinha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Albany St Ste 9b C
Shapiro Bldg
Boston, MA 02118Phone+1 617-414-4290Fax+1 617-414-4285
Education & Training
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2014 - 2017
- University of Virginia School of MedicineClass of 2014
Certifications & Licensure
- MA State Medical License 2018 - 2025
- CT State Medical License 2017 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Enriching tuberculosis research by measuring poverty better: a perspective.Chelsie Cintron, Madolyn Rose Dauphinais, Xinyi Du, Alexa Tabackman, Andrew Lenart
BMC Global and Public Health. 2025-02-21 - Impact of Nutritional Support for Tuberculosis on Intermediate and Terminal Undernutrition and Treatment Outcomes (INSTITUT) study: a protocol for a quasi-experimental...Chelsie Cintron, Madolyn Dauphinais, Attannon Arnauld Fiogbe, Mohammed Fall Dogo, Safiou Ate
BMJ Open. 2025-02-10 - 1 citationsEstimating the epidemiological and economic impact of providing nutritional care for tuberculosis-affected households across India: a modelling study.Christopher Finn McQuaid, Rebecca A Clark, Richard G White, Roel Bakker, Peter Alexander
The Lancet. Global Health. 2025-01-14
Journal Articles
- Meals as Medicine: Feed the Hungry to Treat the Tuberculosis PandemicPranay Sinha, MD, Health Affairs
Press Mentions
- Fact Check: Tuberculosis Is More Dangerous Than COVID-19 but Context MattersAugust 30th, 2020
- Treating COVID-19: Bipolar Drug Shows Promise and Other Hopeful FindingsAugust 21st, 2020
- Severe COVID-19: Interleukin-6 Inhibitors May Be Most EffectiveAugust 10th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: